# North America Advanced Wound Care Market

> North America Advanced Wound Care Market Research Report Information By Product (Dressings (Foam Dressings, Silicone Dressings, Non-silicone Dressings, Collagen Dressings, Hydrofiber Dressings, Wound Contact Layers, Hydrocolloid Dressings, Film Dressings, Alginate Dressings, Hydrogel Dressings, Superabsorbent Dressings, Other Advanced Dressings), Devices & Accessories (NPWT Devices & Accessories, Debridement Devices & Accessories, Wound Assessment & Monitoring Devices, Other Devices & Accessories), Grafts & Matrices, Topical Agents), By Wound Type (Surgical & Traumatic Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, and Burns & Other Wounds), By End User (Hospitals, ASCs, and Wound Care Centers, Home Care Settings, and Other End Users) –North America Market Forecast Till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.1%
- **2024:** $ 6.55 Billion
- **2025:** $ 6.88 Billion
- **2035:** $ 11.32 Billion
- **Key Players:** Smith & Nephew (GB), Mölnlycke Health Care (SE), 3M (US), Acelity (US), ConvaTec(GB), Medtronic (IE), Hollister (US), B. Braun (DE), Coloplast (DK)

**Report ID:** MRFR/Pharma/19802-HCR · **Pages:** 128 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/north-america-advanced-wound-care-market-21352

---

## Market Summary

## **North America Advanced Wound Care Market Overview**

As per MRFR analysis, the North America Advanced Wound Care Market Size was estimated at 6.00 (USD Billion) in 2024. The North America Advanced Wound Care Market Industry is expected to grow from 6.25 (USD Billion) in 2025 to 9.05 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 4.20% during the forecast period (2025 - 2034). One major market driver propelling the need for wound care products is the rising incidence of infections and viruses.

In addition, the market is also anticipated to rise as a result of the aging population with frequently weakened immune systems.

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

## **Advanced Wound Care Market Trends**

### **Rising prevalence of acute and chronic wounds will boost the market growth**

The number of people receiving treatment for chronic wounds is predicted to rise due to the rising prevalence of acute wounds, including surgical and traumatic wounds, as well as chronic wounds, such as diabetic foot ulcers & [venous leg ulcers](../../../reports/venous-leg-ulcer-treatment-market-27946) worldwide, which will propel the market CAGR. Furthermore, the growing number of accidents and the growing weight of chronic illnesses among the elderly population are the main causes contributing to the rise in the population with various wounds, which is supporting the market's expansion.

According to a February 2021 Wound Healing Society article, approximately 2.5% of Americans live with chronic wounds that negatively affect their quality of life, and managing wounds has a big financial impact on healthcare. Thus, It is expected that chronic wounds will remain a major clinical, social, and economic challenge because of the aging population, the persistent threat of obesity and diabetes worldwide, and the persistent infection problem.

Significant factors like raising awareness and educating patients and healthcare professionals about advanced wound care are driving the North America advanced wound care market's growth. Healthcare professionals are more likely to use these cutting-edge methods and supplies since they understand the advantages of advanced wound care. Educational programs, conferences, and research publications are essential in order to spread knowledge and encourage best practices in wound management. Additionally, by attending conferences and workshops, healthcare practitioners can stay up to date on the latest innovations in the field and deliver greater care.

Furthermore, as patients get more knowledge about their available alternatives for care, there is a growing need for improved wound care products. The North American advanced wound care market is expanding due in large part to the increased awareness among patients and the medical community. Thus, driving the advanced wound care market revenue.

## **Advanced Wound Care Market Segment Insights**

### **Advanced Wound Care Product Insights**

The North America Advanced Wound Care market segmentation, based on product, includes Dressings (Foam Dressings, Silicone Dressings, Non-silicone Dressings, Collagen Dressings, Hydrofiber Dressings, Wound Contact Layers, Hydrocolloid Dressings, Film Dressings, Alginate Dressings, Hydrogel Dressings, Superabsorbent Dressings, Other Advanced Dressings), Devices & Accessories (NPWT Devices & Accessories, Debridement Devices & Accessories, Wound Assessment & Monitoring Devices, Other Devices & Accessories), Grafts & Matrices, Topical Agents. The dressings segment dominated the market as a result of growing patient education and the growing frequency of HAls.

The increasing incidence of pressure ulcers, venous ulcers, and diabetic ulcers are some of the factors that are driving the dressing segment expansion.

### **Advanced Wound Care Wound Type Insights**

The North America Advanced Wound Care market segmentation, based on wound type, includes Surgical & Traumatic Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, and Burns & Other Wounds. The diabetic foot ulcers category generated the most income due to the fact that diabetes is becoming more commonplace worldwide. Numerous studies have indicated that individuals with uncontrolled diabetes have an increased susceptibility to diabetic foot ulcers, which in turn fuels the growing need for sophisticated wound care solutions within this patient population.

### **Advanced Wound Care End User Insights**

The North America Advanced Wound Care market segmentation, based on end user, includes Hospitals, ASCs, and Wound Care Centers, Home Care Settings, and Other End Users. The hospitals, ASCs, and wound care centers category generated the most income. The primary market drivers driving the growth of this end-user category include the rise in hospital visits for chronic wounds (pressure ulcers, diabetic foot ulcers, & venous leg ulcers), as well as the rising number of infections and hospital-acquired pressure ulcers.

**Figure 1: North America Advanced Wound Care Market, by End User, 2023 & 2032 (USD Billion)**

****

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

### **Advanced Wound Care Country Insights**

The largest global shareholder in the advanced wound care market is North America. It is expected that the market will accelerate due to the rising cases of traffic accidents and sports injuries, as well as the existence of several important players in the area. Adoption is also anticipated to increase due to the rising incidence of both acute and chronic wounds, as well as the increased expense of treating pressure ulcers, diabetic foot ulcers, and surgical wounds.

For instance, estimates from the Agency for Healthcare Research and Quality show that the annual medical costs in the United States for treating pressure ulcers ranged from USD 9.1 to USD 11.6 billion. Furthermore, North America's market dominance is a result of sufficient reimbursement laws in the United States and Canada. In addition, the number of procedures is expected to cause the market in the United States to rise. The Life Span Organization estimates that over 500,000 open heart operations were performed in the US in 2018.

Likewise, AHA Journals estimates that 40,000 or so children in the United States have congenital heart surgery. Since surgical wounds take time to heal, advanced wound care solutions handle the procedure. During the projected period, these factors are anticipated to support the expansion of the United States market

**Figure 2: NORTH AMERICA ADVANCED WOUND CARE MARKET SHARE BY REGION 2023 & 2032 (USD Billion)**

****

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

## **Advanced Wound Care Key Market Players & Competitive Insights**

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the advanced wound care market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the advanced wound care industry must offer cost-effective items.

Major players in the advanced wound care market are attempting to increase market demand by investing in research and development operations, including 3M Company (US), Smith & Nephew plc (UK), Coloplast A/S (Denmark), Convalec Group Plc (UK), and Mölnlycke Health Care AB (Sweden).

### **Key Companies in the advanced wound care market include**

- 3M Company (US)
- [Smith & Nephew plc](https://www.smith-nephew.com/en/health-care-professionals/products/advanced-wound-management/shared-wound-care-with-allevyn-life-dressings) (UK)
- Coloplast A/S (Denmark)
- [Convalec Group Plc](https://www.convatecgroup.com/media/press-releases/2021/convatec-awarded-contract-for-advanced-wound-care-products-from-vizient-inc/) (UK)
- Mölnlycke Health Care AB (Sweden)

## **North America Advanced Wound Care Market Industry Developments**

- **Q2 2024: Smith+Nephew launches new PICO 7Y negative pressure wound therapy system in the US** Smith+Nephew announced the US launch of its PICO 7Y system, an advanced negative pressure wound therapy device designed to improve healing outcomes for complex wounds. The product launch expands the company's advanced wound care portfolio in North America.
- **Q2 2024: Coloplast acquires Kerecis for $1.3 billion to expand advanced wound care portfolio** Coloplast completed the acquisition of Kerecis, an Icelandic company specializing in fish-skin-based wound care products, strengthening its presence in the North American advanced wound care market.
- **Q1 2024: Convatec launches ConvaFoam advanced wound dressing in North America** Convatec announced the North American launch of ConvaFoam, a new advanced wound dressing designed to manage exudate and promote healing in chronic and acute wounds.
- **Q2 2024: Organogenesis receives FDA 510(k) clearance for PuraPly MZ MicroMatrix wound care device** Organogenesis announced it received FDA 510(k) clearance for its PuraPly MZ MicroMatrix, a new device for the management of acute and chronic wounds, enabling expanded use in US healthcare settings.
- **Q1 2024: MIMEDX Group announces FDA approval of AMNIOEFFECT for chronic wound management** MIMEDX Group received FDA approval for AMNIOEFFECT, an amniotic tissue-based product indicated for the treatment of chronic wounds, further expanding its advanced wound care offerings in the US.
- **Q2 2024: Integra LifeSciences opens new manufacturing facility in Massachusetts to expand wound care production** Integra LifeSciences inaugurated a new manufacturing facility in Massachusetts dedicated to the production of advanced wound care products, aiming to meet growing demand in North America.
- **Q1 2024: Avery Dennison Medical appoints new President to lead advanced wound care business** Avery Dennison Medical announced the appointment of a new President to oversee its advanced wound care division, signaling a strategic focus on growth in the North American market.
- **Q2 2024: Essity launches Cutimed Siltec B advanced foam dressing in North America** Essity introduced Cutimed Siltec B, a new advanced foam dressing for wound management, to the North American market, expanding its product portfolio for chronic and acute wound care.
- **Q1 2024: Bioventus announces partnership with Trice Medical to distribute advanced wound care solutions in the US** Bioventus entered into a partnership with Trice Medical to distribute its advanced wound care products across the United States, enhancing its distribution network and market reach.
- **Q2 2024: Owens & Minor expands advanced wound care distribution center in Texas** Owens & Minor announced the expansion of its Texas distribution center to support increased demand for advanced wound care products in the North American market.
- **Q1 2024: Cardinal Health launches new hydrocolloid dressing for advanced wound care in North America** Cardinal Health introduced a new hydrocolloid dressing designed for advanced wound care applications, targeting hospitals and clinics across North America.
- **Q2 2024: Zimmer Biomet announces strategic partnership with Medline for advanced wound care product distribution** Zimmer Biomet formed a strategic partnership with Medline to distribute its advanced wound care products throughout North America, aiming to increase market penetration and accessibility.

## **Advanced Wound Care Market Segmentation**

### **Advanced Wound Care Product Outlook**

- Dressings
- Foam Dressings
- Silicone Dressings
- Non-silicone Dressings
- Hydrocolloid Dressings
- Film Dressings
- Collagen Dressings
- Hydrofiber Dressings
- Alginate Dressings
- Hydrogel Dressings
- Wound Contact Layers
- Superabsorbent Dressings
- Other Advanced Dressings
- Devices & Accessories
- NPWT Devices & Accessories
- Wound Assessment & Monitoring Devices
- Debridement Devices & Accessories
- Other Devices & Accessories
- Grafts & Matrices
- Topical Agents

### **Advanced Wound Care Wound Type Outlook**

- Surgical & Traumatic Wounds
- Diabetic Foot Ulcers
- Pressure Ulcers
- Venous Leg Ulcers
- Burns & Other Wounds

### **Advanced Wound Care End User Outlook**

- Hospitals, ASCs, and Wound Care Centers
- Home Care Settings
- Other End Users

### **Advanced Wound Care Regional Outlook**

- North America
- United States
- Canada
- Mexico
- Rest of North America

## Market Drivers

### Rising Awareness and Education

There is a growing awareness regarding the importance of effective wound management in North America, which is positively influencing the advanced wound-care market. Educational initiatives aimed at healthcare professionals and patients are increasing understanding of advanced wound-care products and their benefits. This heightened awareness is leading to more informed decision-making in treatment options, thereby driving demand. The advanced wound-care market is witnessing a shift as healthcare providers prioritize education and training, ensuring that both patients and practitioners are equipped with the knowledge necessary for optimal wound care. As awareness continues to rise, the market is expected to expand, reflecting the need for effective wound management solutions.

### Aging Population and Healthcare Demand

The demographic shift towards an aging population in North America is significantly impacting the advanced wound-care market. As individuals age, they become more susceptible to wounds and skin-related issues, leading to an increased demand for advanced wound-care products. By 2030, it is estimated that around 20% of the U.S. population will be over 65 years old, which correlates with a higher incidence of chronic wounds. This demographic trend is prompting healthcare providers to invest in advanced wound-care solutions that cater to the needs of older patients. The advanced wound-care market is thus likely to see sustained growth as healthcare systems adapt to the challenges posed by an aging population.

### Technological Innovations in Treatment

Technological advancements play a crucial role in shaping the advanced wound-care market in North America. Innovations such as bioengineered skin substitutes, negative pressure wound therapy, and advanced dressings are transforming treatment protocols. The integration of smart technologies, including telemedicine and mobile health applications, enhances patient monitoring and care delivery. The market is projected to reach approximately $10 billion by 2026, reflecting a compound annual growth rate (CAGR) of around 6.5%. These innovations not only improve healing outcomes but also reduce healthcare costs, making them attractive to both providers and patients. The advanced wound-care market is thus positioned to benefit from ongoing research and development efforts aimed at enhancing treatment efficacy.

### Increasing Incidence of Chronic Diseases

The advanced wound-care market in North America is experiencing growth due to the rising incidence of chronic diseases such as diabetes and obesity. These conditions often lead to complications like diabetic foot ulcers and pressure sores, necessitating advanced wound-care solutions. According to recent data, approximately 30.3 million people in the U.S. have diabetes, which significantly increases the demand for specialized wound care. The advanced wound-care market is adapting to this trend by developing innovative products that cater to the unique needs of patients with chronic conditions. As the population ages and the prevalence of chronic diseases continues to rise, the market is likely to expand further, driven by the need for effective wound management solutions.

### Healthcare Policy and Reimbursement Changes

Changes in healthcare policies and reimbursement frameworks are significantly impacting the advanced wound-care market in North America. Recent reforms have aimed to improve access to advanced wound-care treatments, making them more affordable for patients. Insurance coverage for advanced wound-care products is expanding, which is likely to enhance market penetration. The advanced wound-care market is adapting to these changes by aligning product offerings with reimbursement guidelines, ensuring that healthcare providers can offer the best care without financial constraints. As policies continue to evolve, the market is expected to grow, driven by increased accessibility and affordability of advanced wound-care solutions.

## Future Outlook

The advanced wound-care market is projected to grow at a 5.1% CAGR from 2025 to 2035, driven by technological advancements, increasing chronic diseases, and rising healthcare expenditures.

**New opportunities:**

- Development of smart wound dressings with integrated sensors
- Expansion of telehealth services for remote wound management
- Investment in biodegradable wound care products to meet sustainability demands

By 2035, the advanced wound-care market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Product Type: Negative Pressure Wound Therapy (Largest) vs. Advanced Dressings (Fastest-Growing)

In the North America advanced wound-care market, Negative Pressure Wound Therapy (NPWT) holds the largest market share due to its effectiveness in treating complex wounds and its wide acceptance among healthcare professionals. Advanced Dressings, while currently a smaller segment, are rapidly gaining traction thanks to innovative materials and technology that enhance healing and patient comfort.

Growth trends in this segment are primarily driven by an increasing prevalence of chronic wounds and a rising geriatric population. Additionally, technological advancements in dressing materials and NPWT systems contribute to market dynamism. The focus on improving patient outcomes and minimizing hospital stays is also propelling the adoption of these therapies, paving the way for new entrants and products to emerge in the market.

Negative Pressure Wound Therapy (Dominant) vs. Advanced Dressings (Emerging)

Negative Pressure Wound Therapy (NPWT) is characterized by its ability to expedite wound healing through the application of controlled negative pressure, making it a preferred choice among clinicians for complex wounds. This dominant segment has established a solid market presence supported by robust clinical evidence demonstrating its efficacy. On the other hand, Advanced Dressings are increasingly recognized for their versatility and adaptability in treating various wound types. These dressings incorporate advanced materials, such as hydrocolloids and foams, which not only aid in moisture management but also promote faster healing. As the demand for less invasive and more effective wound care options rises, Advanced Dressings are carving their niche as an emerging segment within the dynamic landscape.

### By Wound Type: Diabetic Wounds (Largest) vs. Pressure Ulcers (Fastest-Growing)

In the advanced wound-care market, Diabetic Wounds account for a significant share, positioning themselves as the largest segment due to the increasing prevalence of diabetes. Following closely are Pressure Ulcers, which have emerged as a crucial concern in healthcare settings, garnering notable attention and resources for management and treatment. This distribution illustrates a dynamic interaction between chronic conditions and acute care requirements, emphasizing the importance of targeted wound-care solutions.

Growth trends in this segment are propelled by a rising aging population and the increasing incidence of chronic diseases, particularly diabetes. Additionally, awareness regarding advanced treatment options is fostering demand for effective wound management strategies. Healthcare professionals are increasingly prioritizing preventive measures for Pressure Ulcers, driving innovation in this field and contributing to its status as the fastest-growing category within the market.

Diabetic Wounds (Dominant) vs. Surgical Wounds (Emerging)

Diabetic Wounds represent the dominant force in the advanced wound-care market, characterized by their complex nature and significant treatment demand owing to the challenges posed by diabetes-related complications. This segment focuses on extensive care, utilizing advanced products such as dressings and biological treatments specifically designed for effective healing. In contrast, Surgical Wounds are emerging as an important segment within this market. They require precision in management to prevent infection and expedite recovery, and innovative wound-care solutions are being developed to meet these challenges. Both segments reflect distinct healthcare priorities, with Diabetic Wounds emphasizing chronic disease management, while Surgical Wounds focus on post-operative care advancements.

### By End User: Hospitals (Largest) vs. Home Care Settings (Fastest-Growing)

In the advanced wound-care market, hospitals form the largest segment, commanding a significant share of the overall market. Clinics and ambulatory surgical centers are also vital, while nursing homes and home care settings are gaining traction, particularly due to the increasing preference for at-home treatments. 

Growth in this segment is propelled by an aging population and rising incidences of chronic wounds. Home care settings are emerging as the fastest-growing segment, driven by technological advancements that enable better remote monitoring and treatment. Increased focus on cost-effective solutions also favors the shift towards home care, enhancing patient comfort and recovery rates.

Hospitals (Dominant) vs. Home Care Settings (Emerging)

Hospitals represent the dominant force in the advanced wound-care segment, characterized by their capacity to utilize advanced treatments and technologies. They are equipped with specialized staff and infrastructure, enabling complex procedures and care management. In contrast, home care settings are an emerging segment, driven by the need for convenience and effective management of mild to moderate wounds. The preference for personalized care at home, combined with effective remote patient monitoring tools, is reshaping the market landscape, prompting innovations that cater to these new care models.

## Regional Market Share Analysis

### US : Robust Growth and Innovation Hub

The US advanced wound-care market holds a significant share of 5.2%, driven by increasing incidences of chronic wounds and a growing elderly population. Key growth drivers include advancements in technology, rising healthcare expenditure, and supportive government initiatives aimed at improving healthcare access. Regulatory policies, such as the FDA's streamlined approval processes for innovative wound-care products, further enhance market dynamics. Additionally, robust healthcare infrastructure and industrial development contribute to the market's expansion.

### Canada : Focus on Quality and Accessibility

Canada's advanced wound-care market, valued at 1.35%, is characterized by a growing demand for high-quality wound management solutions. Key growth drivers include an aging population, increased awareness of advanced wound care, and government initiatives promoting healthcare accessibility. The Canadian healthcare system's emphasis on patient-centered care and innovative treatment options is shaping consumption patterns. Regulatory frameworks support the introduction of new technologies, enhancing market competitiveness.

## Competitive Benchmarking

The North America Advanced Wound Care Market is characterized by a dynamic competitive landscape, driven by a confluence of innovation, strategic partnerships, and a growing emphasis on patient-centric solutions. Key players such as Smith & Nephew (GB), Mölnlycke Health Care (SE), and Acelity (US) are actively shaping the market through their distinct operational focuses. Smith & Nephew (GB) emphasizes innovation in advanced wound management technologies, while Mölnlycke Health Care (SE) is known for its commitment to sustainability and eco-friendly product lines. Acelity (US), on the other hand, has been focusing on expanding its product portfolio through strategic acquisitions, thereby enhancing its market presence. Collectively, these strategies contribute to a competitive environment that is increasingly oriented towards technological advancement and sustainability.
In terms of business tactics, companies are increasingly localizing manufacturing to enhance supply chain efficiency and reduce lead times. This approach not only optimizes operational costs but also aligns with the growing demand for rapid product availability in the healthcare sector. The market structure appears moderately fragmented, with several key players exerting influence while also allowing for niche companies to thrive. The collective actions of these major players are pivotal in shaping market dynamics, as they navigate the complexities of regulatory environments and evolving consumer preferences.
In August 2025, Smith & Nephew (GB) announced the launch of a new line of antimicrobial dressings designed to enhance healing rates in chronic wounds. This strategic move underscores the company's commitment to innovation and addresses the increasing demand for effective wound care solutions. By leveraging advanced materials and technology, Smith & Nephew (GB) aims to solidify its position as a leader in the advanced wound care segment, potentially capturing a larger market share.
In September 2025, Mölnlycke Health Care (SE) entered into a partnership with a leading telehealth provider to integrate digital health solutions into its wound care offerings. This collaboration is indicative of a broader trend towards digitalization in healthcare, allowing for remote monitoring and management of wound care. Such initiatives not only enhance patient engagement but also streamline care processes, positioning Mölnlycke Health Care (SE) favorably in a competitive landscape increasingly focused on technology integration.
In July 2025, Acelity (US) completed the acquisition of a smaller biotech firm specializing in regenerative medicine. This acquisition is strategically significant as it expands Acelity's capabilities in advanced wound care, particularly in the area of biologics. By integrating these innovative solutions into its existing product line, Acelity (US) is likely to enhance its competitive edge and address the growing demand for advanced therapeutic options in wound management.
As of October 2025, the competitive trends in the North America Advanced Wound Care Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in enhancing product offerings and market reach. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability, thereby reshaping the landscape of advanced wound care.

## Recent News & Developments

- **Q2 2024: Smith+Nephew launches new PICO 7Y negative pressure wound therapy system in the US** Smith+Nephew announced the US launch of its PICO 7Y system, an advanced negative pressure wound therapy device designed to improve healing outcomes for complex wounds. The product launch expands the company's advanced wound care portfolio in North America.
- **Q2 2024: Coloplast acquires Kerecis for $1.3 billion to expand advanced wound care portfolio** Coloplast completed the acquisition of Kerecis, an Icelandic company specializing in fish-skin-based wound care products, strengthening its presence in the North American advanced wound care market.
- **Q1 2024: Convatec launches ConvaFoam advanced wound dressing in North America** Convatec announced the North American launch of ConvaFoam, a new advanced wound dressing designed to manage exudate and promote healing in chronic and acute wounds.
- **Q2 2024: Organogenesis receives FDA 510(k) clearance for PuraPly MZ MicroMatrix wound care device** Organogenesis announced it received FDA 510(k) clearance for its PuraPly MZ MicroMatrix, a new device for the management of acute and chronic wounds, enabling expanded use in US healthcare settings.
- **Q1 2024: MIMEDX Group announces FDA approval of AMNIOEFFECT for chronic wound management** MIMEDX Group received FDA approval for AMNIOEFFECT, an amniotic tissue-based product indicated for the treatment of chronic wounds, further expanding its advanced wound care offerings in the US.
- **Q2 2024: Integra LifeSciences opens new manufacturing facility in Massachusetts to expand wound care production** Integra LifeSciences inaugurated a new manufacturing facility in Massachusetts dedicated to the production of advanced wound care products, aiming to meet growing demand in North America.
- **Q1 2024: Avery Dennison Medical appoints new President to lead advanced wound care business** Avery Dennison Medical announced the appointment of a new President to oversee its advanced wound care division, signaling a strategic focus on growth in the North American market.
- **Q2 2024: Essity launches Cutimed Siltec B advanced foam dressing in North America** Essity introduced Cutimed Siltec B, a new advanced foam dressing for wound management, to the North American market, expanding its product portfolio for chronic and acute wound care.
- **Q1 2024: Bioventus announces partnership with Trice Medical to distribute advanced wound care solutions in the US** Bioventus entered into a partnership with Trice Medical to distribute its advanced wound care products across the United States, enhancing its distribution network and market reach.
- **Q2 2024: Owens & Minor expands advanced wound care distribution center in Texas** Owens & Minor announced the expansion of its Texas distribution center to support increased demand for advanced wound care products in the North American market.
- **Q1 2024: Cardinal Health launches new hydrocolloid dressing for advanced wound care in North America** Cardinal Health introduced a new hydrocolloid dressing designed for advanced wound care applications, targeting hospitals and clinics across North America.
- **Q2 2024: Zimmer Biomet announces strategic partnership with Medline for advanced wound care product distribution** Zimmer Biomet formed a strategic partnership with Medline to distribute its advanced wound care products throughout North America, aiming to increase market penetration and accessibility.

## Report Scope

| MARKET SIZE 2024 | 6.55(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 6.88(USD Billion) |
| MARKET SIZE 2035 | 11.32(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.1% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Smith & Nephew (GB), Mölnlycke Health Care (SE), 3M (US), Acelity (US), ConvaTec (GB), Medtronic (IE), Hollister (US), B. Braun (DE), Coloplast (DK) |
| Segments Covered | Product Type, Wound Type, End User |
| Key Market Opportunities | Integration of innovative technologies enhances treatment efficacy in the advanced wound-care market. |
| Key Market Dynamics | Technological advancements drive innovation in advanced wound-care products, enhancing patient outcomes and market competitiveness. |
| Countries Covered | US, Canada |

## Frequently Asked Questions

**Q: What was the market valuation of the advanced wound-care market in 2024?**
A: The market valuation was 6.55 USD Billion in 2024.

**Q: What is the projected market valuation for the advanced wound-care market by 2035?**
A: The projected valuation for 2035 is 11.32 USD Billion.

**Q: What is the expected CAGR for the advanced wound-care market during the forecast period 2025 - 2035?**
A: The expected CAGR during the forecast period 2025 - 2035 is 5.1%.

**Q: Which product type segment had the highest valuation in 2024?**
A: In 2024, the Advanced Dressings segment had the highest valuation at 2.0 USD Billion.

**Q: What is the projected valuation for Negative Pressure Wound Therapy by 2035?**
A: The projected valuation for Negative Pressure Wound Therapy by 2035 is 2.5 USD Billion.

**Q: Which wound type segment is expected to grow the most by 2035?**
A: The Burn Wounds segment is expected to grow the most, with a projected valuation of 2.92 USD Billion by 2035.

**Q: What was the valuation of the Home Care Settings segment in 2024?**
A: The Home Care Settings segment had a valuation of 1.85 USD Billion in 2024.

**Q: Which key player is recognized for its leadership in the advanced wound-care market?**
A: Smith & Nephew is recognized as a key player in the advanced wound-care market.

**Q: What is the projected valuation for the Clinics segment by 2035?**
A: The projected valuation for the Clinics segment by 2035 is 2.28 USD Billion.

**Q: How does the valuation of Surgical Wounds compare to Chronic Wounds in 2024?**
A: In 2024, Surgical Wounds had a valuation of 1.0 USD Billion, while Chronic Wounds had a valuation of 1.3 USD Billion.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/north-america-advanced-wound-care-market-21352*